14 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 1

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CRPC-reactive protein, pentraxin-relatedCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enrichedgallbladder:173.7
liver:532.4
HABP2Hyaluronan binding protein 2Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enrichedgallbladder:56.0
liver:225.6
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enrichedduodenum:44.7
gallbladder:42.8
kidney:20.8
liver:67.6
small intestine:50.5
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol
Group enrichedadipose tissue:352.3
breast:122.0
esophagus:118.4
gallbladder:189.9
liver:186.5
stomach:138.5
urinary bladder:186.3
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumGroup enrichedgallbladder:400.5
liver:1099.6
lung:229.6
CLRN3Clarin 3Predicted membrane proteins
Transporters
Group enrichedcolon:71.2
duodenum:75.4
gallbladder:23.7
kidney:43.9
liver:40.2
rectum:77.5
small intestine:99.5
CYP2C18Cytochrome P450, family 2, subfamily C, polypeptide 18Enzymes
Plasma proteins
Predicted secreted proteins
Group enrichedduodenum:105.9
esophagus:24.7
gallbladder:24.5
liver:97.7
small intestine:90.0
stomach:62.7
F5Coagulation factor V (proaccelerin, labile factor)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enrichedgallbladder:28.5
liver:93.7
placenta:67.7
NR1I2Nuclear receptor subfamily 1, group I, member 2FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmGroup enrichedcolon:9.3
duodenum:23.2
gallbladder:6.0
liver:19.7
rectum:9.4
small intestine:26.3
ONECUT1One cut homeobox 1Predicted intracellular proteins
Transcription factors
Group enrichedgallbladder:8.5
liver:5.9
pancreas:2.3
testis:1.8
SLC17A4Solute carrier family 17, member 4Predicted membrane proteins
Transporters
Group enrichedcolon:20.8
duodenum:29.4
gallbladder:25.5
liver:22.4
rectum:29.4
small intestine:35.7
TM4SF4Transmembrane 4 L six family member 4Predicted membrane proteins
Transporters
Plasma membrane
Cytosol
Group enrichedduodenum:595.8
gallbladder:1326.5
liver:343.7
small intestine:515.2
UGT2B15UDP glucuronosyltransferase 2 family, polypeptide B15Enzymes
Predicted membrane proteins
Group enrichedcolon:23.8
duodenum:30.6
gallbladder:114.5
liver:108.6
small intestine:33.9
VNN1Vanin 1Enzymes
Plasma proteins
Predicted secreted proteins
Group enrichedduodenum:176.1
gallbladder:175.5
liver:142.6
small intestine:108.8

Page of 1